Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1950 1
1951 1
1952 1
1958 1
1959 3
1961 2
1962 6
1963 2
1964 2
1965 2
1966 2
1967 6
1968 1
1969 3
1970 2
1971 6
1972 1
1973 5
1974 3
1976 5
1978 6
1979 3
1980 5
1981 5
1982 1
1984 6
1985 8
1986 7
1987 8
1988 4
1989 8
1990 7
1991 5
1992 3
1993 5
1994 3
1995 2
1996 5
1997 4
1998 2
1999 6
2000 8
2001 3
2002 8
2003 8
2004 6
2005 10
2006 14
2007 7
2008 25
2009 26
2010 24
2011 14
2012 20
2013 32
2014 33
2015 31
2016 48
2017 58
2018 56
2019 67
2020 82
2021 71
2022 59
2023 62
2024 74
2025 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

956 results

Results by year

Filters applied: . Clear all
Page 1
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, Sharrack B, Snowden JA, Tarte K, Onida F, Sánchez-Ortega I, Burman J, Castilla Llorente C, Cervera R, Ciceri F, Doria A, Henes J, Lindsay J, Mackensen A, Muraro PA, Ricart E, Rovira M, Zuckerman T, Yakoub-Agha I, Farge D. Greco R, et al. Among authors: alexander t. EClinicalMedicine. 2024 Feb 10;69:102476. doi: 10.1016/j.eclinm.2024.102476. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361991 Free PMC article. Review.
Autoimmune Disease.
Alexander T, Sharrack B, Rovira M, Saccardi R, Farge D, Snowden JA, Greco R. Alexander T, et al. 2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024. Chapter 92. 2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editors. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024. Chapter 92. PMID: 39437071 Free Books & Documents. Review.
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.
Passweg JR, Baldomero H, Atlija M, Kleovoulou I, Witaszek A, Alexander T, Angelucci E, Averbuch D, Bazarbachi A, Ciceri F, Greco R, Hazenberg MD, Kalwak K, McLornan DP, Neven B, Perić Z, Risitano AM, Ruggeri A, Sánchez-Ortega I, Snowden JA, Sureda A. Passweg JR, et al. Among authors: alexander t. Bone Marrow Transplant. 2025 Apr;60(4):519-528. doi: 10.1038/s41409-025-02524-2. Epub 2025 Feb 12. Bone Marrow Transplant. 2025. PMID: 39939433 Free PMC article.
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation.
Siegert E, Biesen R, Dzamukova M, Furth C, Probst M, Doellinger F, Walter-Rittel T, Fleischmann A, Wilhelm A, Beenken AE, Wiebe E, Pecher AC, Henes J, Florian S, Simon D, Kleyer A, Burmester GR, Keller U, Krönke J, Krönke G, Alexander T. Siegert E, et al. Among authors: alexander t. Ann Rheum Dis. 2025 Apr;84(4):653-656. doi: 10.1016/j.ard.2025.01.043. Epub 2025 Feb 24. Ann Rheum Dis. 2025. PMID: 40000264 No abstract available.
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework.
Della-Torre E, Talarico R, Ballarin J, Bozzalla-Cassione E, Cardamone C, Cigolini C, Ferro F, Fonseca T, Fragoulis GE, Galetti I, Gerosa M, Hernández-Rodríguez J, Lanzillotta M, Marinello D, Martin T, Martinez-Valle F, Maślińska M, Moretti M, Mosca M, Müller-Ladner U, Nalli C, Orsolini G, Pamfil C, Perez-Garcia G, Priori R, Quattrocchio G, Ramming A, Regola F, Romão VC, Silva A, van Laar JAM, Vicente-Edo MJ, Vinker S, Alexander T. Della-Torre E, et al. Among authors: alexander t. Lancet Rheumatol. 2025 Jan;7(1):e64-e71. doi: 10.1016/S2665-9913(24)00192-9. Epub 2024 Oct 29. Lancet Rheumatol. 2025. PMID: 39486422 Review.
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Minopoulou I, Wilhelm A, Albach F, Kleyer A, Wiebe E, Schallenberg S, Fleischmann A, Frick M, Damm F, Gogolok J, Serve S, Locher BN, Borie D, Casteleyn V, Biesen R, Dörner T, Alexander T, Zernicke J, Movassaghi K, Hütter-Krönke ML, Schrezenmeier E, Schreiber A, Schneider U, Bullinger L, Krönke G, Penack O, Simon D. Minopoulou I, et al. Among authors: alexander t. Ann Rheum Dis. 2025 Mar;84(3):e4-e7. doi: 10.1016/j.ard.2025.01.008. Epub 2025 Jan 31. Ann Rheum Dis. 2025. PMID: 39893102 No abstract available.
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis.
Albach FN, Minopoulou I, Wilhelm A, Biesen R, Kleyer A, Wiebe E, Fleischmann A, Frick M, Damm F, Gogolok J, Serve S, Locher BN, Borie D, Casteleyn V, Siegert E, Dörner T, Alexander T, Furth C, Zernicke J, Movassaghi K, Hütter-Krönke ML, Schrezenmeier E, Schneider U, Bullinger L, Krönke G, Penack O, Simon D. Albach FN, et al. Among authors: alexander t. Rheumatology (Oxford). 2025 Jun 1;64(6):4075-4077. doi: 10.1093/rheumatology/keaf077. Rheumatology (Oxford). 2025. PMID: 39928370 No abstract available.
956 results